"The way in which it could
be somewhat bad for PBMs is pretty indirect. It's the idea that Amazon is now
going to be showing every Prime customer two prices for every pharmacy
transaction…it's really going to highlight the disparities of the cost to you of
any given drug if you use insurance or if you choose not to use
insurance."
— SVB Leerink analyst Stephen Tanal talked with AIS's RADAR on Drug Benefits
about whether the launch of Amazon Pharmacy will pose a threat to the PBM
business model.
Subscribers may read the RADAR on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment